Indications and Purposes
| 1 Indications And Usage Adcirca Is A Phosphodiesterase 5 (Pde5) Inhibitor Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve Exercise Ability. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Ii – Iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (61%) Or Pah Associated With Connective Tissue Diseases (23%). ( 1.1 ) 1.1 Pulmonary Arterial Hypertension Adcirca ® Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1) To Improve Exercise Ability. Studies Establishing Effectiveness Included Predominately Patients With Nyha Functional Class Ii – Iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (61%) Or Pah Associated With Connective Tissue Diseases (23%). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Tadalafil |
|
ZINC3993855 |